Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Vivanza Biosciences Ltd

NSE: VIVANZA · BSE: 530057 · Pharmaceuticals & Biotechnology · 20 announcements

Share price
₹1.70
Market cap
₹6.80 Cr
Revenue (annual)
₹115.9 Cr
Net profit (annual)
₹0.39 Cr
P/E (TTM)
15.0×Sector 47.3×
Promoter holding
20.02%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:44 IST BSE
Management Change

Vivanza Biosciences Management Change

Vivanza Biosciences appointed Mr. Vishal Sureshbhai Katarmal as Company Secretary and Compliance Officer. The Board also noted a strategic agreement for a manufacturing project in Kyrgyzstan.

16:05 IST BSE
Management Change

Vivanza Biosciences Management Change

Mr. Chaitra Arora has resigned as Company Secretary and Compliance Officer of Vivanza Biosciences Limited, effective April 30, 2026. He is departing to pursue career opportunities outside the company. The board has acknowledged the resignation, noting no material reasons for his departure other than personal professional growth.